<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044377</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Participation by a third party in the practice of pharmacy compounding. How far does it go?</dc:title>
<dc:description xml:lang="en">The present paper is a comparative study of how regulate Spain, Germany and    France the participation by a third party in the practice of pharmacy compounding.    It is analysed in which situations this participation can be carried out and    what establishments are authorized to do this</dc:description>
<dc:creator>Bel, Elvira</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En el trabajo se realiza un estudio comparativo de cómo regulan España, Alemania    y Francia le elaboración por terceros en la realización de fórmulas magistrales.    Se analizan en qué situaciones puede realizarse y qué establecimientos    pueden llevarlo a cabo</dc:description>
<dc:source>An Real Acad Farm;71(4): 799-812, oct. 2005.</dc:source>
<dc:identifier>ibc-044377</dc:identifier>
<dc:title xml:lang="es">Elaboración por terceros en la formulación magistral. ¿Hasta dónde llega?</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2672^s22034</dc:subject>
<dc:subject>^d2672^s22045</dc:subject>
<dc:subject>^d2672^s22066</dc:subject>
<dc:subject>^d8059^s22049</dc:subject>
<dc:subject>^d8059^s22048</dc:subject>
<dc:subject>^d2672^s22019</dc:subject>
<dc:subject>^d2672^s22049</dc:subject>
<dc:subject>^d23106^s22048</dc:subject>
<dc:subject>^d23106^s22034</dc:subject>
<dc:type>article</dc:type>
<dc:date>200510</dc:date>
</metadata>
</record>
</ibecs-document>
